Newby LK - Search Results

1

Trends in use of anti-thrombotic agents and outcomes in patients with non-ST-segment elevation myocardial infarction (NSTEMI) managed with an invasive strategy.

Wayangankar SA, Roe MT, Chen AY, Gupta RS, Giugliano RP, Newby LK, de Lemos JA, Alexander KP, Sanborn TA, Saucedo JF. Wayangankar SA, et al. Among authors: newby lk. Indian Heart J. 2016 Jul-Aug;68(4):464-72. doi: 10.1016/j.ihj.2015.09.036. Epub 2016 Jan 18. Indian Heart J. 2016. PMID: 27543467 Free PMC article.

2

Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial.

Newby LK, Marber MS, Melloni C, Sarov-Blat L, Aberle LH, Aylward PE, Cai G, de Winter RJ, Hamm CW, Heitner JF, Kim R, Lerman A, Patel MR, Tanguay JF, Lepore JJ, Al-Khalidi HR, Sprecher DL, Granger CB; SOLSTICE Investigators. Newby LK, et al. Lancet. 2014 Sep 27;384(9949):1187-95. doi: 10.1016/S0140-6736(14)60417-7. Epub 2014 Jun 12. Lancet. 2014. PMID: 24930728 Clinical Trial.

3

Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up.

Alexander KP, Newby LK, Hellkamp AS, Harrington RA, Peterson ED, Kopecky S, Langer A, O'Gara P, O'Connor CM, Daly RN, Califf RM, Khan S, Fuster V. Alexander KP, et al. Among authors: newby lk. J Am Coll Cardiol. 2001 Jul;38(1):1-7. doi: 10.1016/s0735-1097(01)01329-8. J Am Coll Cardiol. 2001. PMID: 11451256 Free article.

4

Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation.

Lopes RD, Pieper KS, Horton JR, Al-Khatib SM, Newby LK, Mehta RH, Van de Werf F, Armstrong PW, Mahaffey KW, Harrington RA, Ohman EM, White HD, Wallentin L, Granger CB. Lopes RD, et al. Among authors: newby lk. Heart. 2008 Jul;94(7):867-73. doi: 10.1136/hrt.2007.134486. Epub 2008 Mar 10. Heart. 2008. PMID: 18332062

5

Predictors of 90-day outcome in patients stabilized after acute coronary syndromes.

Newby LK, Bhapkar MV, White HD, Topol EJ, Dougherty FC, Harrington RA, Smith MC, Asarch LF, Califf RM; SYMPHONY and 2nd SYMPHONY Investigators. Newby LK, et al. Eur Heart J. 2003 Jan;24(2):172-81. doi: 10.1016/s0195-668x(02)00325-1. Eur Heart J. 2003. PMID: 12573274 Clinical Trial.

6

Time-based risk assessment after myocardial infarction. Implications for timing of discharge and applications to medical decision-making.

Newby LK, Hasselblad V, Armstrong PW, Van de Werf F, Mark DB, White HD, Topol EJ, Califf RM. Newby LK, et al. Eur Heart J. 2003 Jan;24(2):182-9. doi: 10.1016/s0195-668x(02)00301-9. Eur Heart J. 2003. PMID: 12573275

7

Long-term oral platelet glycoprotein IIb/IIIa receptor antagonism with sibrafiban after acute coronary syndromes: study design of the sibrafiban versus aspirin to yield maximum protection from ischemic heart events post-acute coronary syndromes (SYMPHONY) trial. Symphony Steering Committee.

Newby LK. Newby LK. Am Heart J. 1999 Aug;138(2 Pt 1):210-8. doi: 10.1016/s0002-8703(99)70104-3. Am Heart J. 1999. PMID: 10426831

8

Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy.

Alexander JH, Sparapani RA, Mahaffey KW, Deckers JW, Newby LK, Ohman EM, Corbalán R, Chierchia SL, Boland JB, Simoons ML, Califf RM, Topol EJ, Harrington RA. Alexander JH, et al. Among authors: newby lk. JAMA. 2000 Jan 19;283(3):347-53. doi: 10.1001/jama.283.3.347. JAMA. 2000. PMID: 10647797

9

Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy.

Newby LK, Ohman EM, Christenson RH, Moliterno DJ, Harrington RA, White HD, Armstrong PW, Van De Werf F, Pfisterer M, Hasselblad V, Califf RM, Topol EJ. Newby LK, et al. Circulation. 2001 Jun 19;103(24):2891-6. doi: 10.1161/01.cir.103.24.2891. Circulation. 2001. PMID: 11413076 Clinical Trial.

10

Relation between baseline risk and treatment decisions in non-ST elevation acute coronary syndromes: an examination of international practice patterns.

Kaul P, Newby LK, Fu Y, Mark DB, Goodman SG, Wagner GS, Harrington RA, Granger CB, Van de Werf F, Ohman EM, Armstrong PW; VIGOUR Group. Kaul P, et al. Among authors: newby lk. Heart. 2005 Jul;91(7):876-81. doi: 10.1136/hrt.2004.042887. Heart. 2005. PMID: 15958353 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

476 results

Search Page